← SynDRA
TELMISARTAN
SynDRA canonical compound SYN0003165 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | PPARG |
|---|
| Mechanism of action | Angiotensin receptor antagonist |
|---|
| Indication | hypertension |
|---|
| Disease area | cardiology |
|---|
All known targets
- AGTR1
- PPARG
- ABCG2
- ACE
- AGTR2
- Agtr1
- Agtr1b
- CYP2C19
- CYP2J2
- GLRA1
- PPARA
- SLC47A1
Mechanisms of action (all sources)
- Angiotensin receptor antagonist
- AGTR1 ANTAGONIST
- Type-1 angiotensin II receptor antagonist
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ABCB11
- ADRA2A
- OPRM1
- CYP2C9
- CHRM2
- CCKAR
- SLCO1B1
- SLCO1B3
- TBXA2R
- PDE4D
- ADRA1A
- HTR2B
- TACR1
- MC4R
- NR3C1
- NR1I2
- NPY2R
- NPY1R
- NPSR1
- NFE2L2
- NEIL2
- NEIL1
- MUTYH
- MPG
- MLNR
- MC3R
- STAT5A
- MBD4
- MAPK1
- MAOA
- KDR
- KDM4E
- KCNH2
- IDH1
- HTR7
- HTR6
- HTR3A
- HTR2C
- NTSR1
- OPRD1
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- CP2C9
- CP2CJ
- ESRRA
- KSYK
- NF2L2
- S12A5
- SC6A3
- SYK
- UBP1
Drug classes
- Angiotensin 2 Receptor Antagonists
- Angiotensin 2 Receptor Blocker
- Angiotensin II Type 1 Receptor Blockers
- Angiotensin Receptor Antagonists
- Antihypertensive Agents
- Cardiovascular Agents
ATC classes
- C09C · ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), PLAIN
- ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS
Cross-references
Synonyms
- MICARDIS
- MICARDIS HCT
- Micardis
- Semintra
- TELMISARTAN AND AMLODIPINE
- TELMISARTAN AND HYDROCHLOROTHIAZIDE
- TWYNSTA
- Twynsta
- WIDAPLIK
- tolura
- micardis
- pritor
- Bibr-277se
- Kinzalmono
- Pritor
- Telmisartan actavis
- Telmisartan teva
- BIBR-277-SE
- BIBR-277
- C09CA07
- Kinzalmono (previously telmisartan boehringer ingelheim pharma kg)
- Telmisartan component of kinzalkomb
- Telmisartan component of micardis hct
- Telmisartan component of micardisplus
- Telmisartan component of onduarp
- Telmisartan component of pritorplus
- Telmisartan component of tolucombi
- Telmisartan component of twynsta
- Telmisartan teva pharma
- Tolura
- Kinzal
- Abbott brand of telmisartan
- Boehringer Ingelheim brand of telmisartan
- Glaxo Wellcome brand of telmisartan
- GlaxoSmithKline brand of telmisartan
- BIBR-277SE
- Bay 68-9291
Reported adverse events
- Hypotension
- Back pain
- Upper respiratory tract infection
- Angioedema
- Abdominal pain
- Renal impairment
- Pharyngitis
- Cough
- Myalgia
- Dizziness
- Anaphylactic reaction
- Sinusitis
Look up TELMISARTAN in the interactive SynDRA portal →